Navigation Links
ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
Date:8/19/2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Dec. 15 AstraZeneca (NYSE: ... Virginia (UVa) in Charlottesville, today announced that ... collaboration to enhance development of new treatments ... a secondary focus on peripheral vascular disease ... ,, The collaborative preclinical research projects will ...
(Date:12/15/2009)... Dec. 15 On January 20th, 2010, ... for Medical Publication Professionals (ISMPP) will be held ... UK. More than 100 attendees are expected at ... publication professionals, editors, publishers, medical writers and medical ... publications and the impact of guidelines and regulations ...
(Date:12/14/2009)... 14 Vermillion, Inc. (Pink Sheets: ... William C. Wallen, Ph.D. Chief Scientific Officer, ... IDEXX Laboratories, will be joining its board ... plan. ,, "Bill brings more than ... diagnostics and biotechnology," said Gail Page, Vermillion ...
(Date:12/14/2009)... Dec. 14 Lionbridge (Nasdaq: ... signed a new, three-year master services agreement ... products and services that serve patients in ... will become the sole provider for translation ... regulatory, marketing, training, human resources, legal, and ...
Breaking Biology Technology:AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 2AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 3Announcing ISMPP EU 2010 - the First European Meeting of the International Society for Medical Publication Professionals, Royal College of Physicians, London, UK, January 20, 2010 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 2Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 3
... - Canadian Biotechnology Company demonstrates the technical feasibility of ... in safflower - ... TSX symbol: SBS, ... company developing a portfolio of therapeutic,proteins for metabolic and cardiovascular diseases, ...
... 3 data available by spring 2009 to support, ... 2009 -, ROCKVILLE, Md., Nov. 1 Human ... it has completed enrollment and,initial dosing ahead of schedule ... 3 trials of Albuferon(R) (albinterferon alfa-2b) in,combination with ribavirin ...
... Blood ... Sugar Management, BRIDGEWATER, N.J., Nov. 1 ... nominated actress and,Broadway star Aida Turturro is teaming up with sanofi-aventis, a ... levels of blood sugar control. Ms. Turturro,s personal story can be,seen in ...
Other Biology Technology:SemBioSys announces 2007 third quarter results 2SemBioSys announces 2007 third quarter results 3SemBioSys announces 2007 third quarter results 4SemBioSys announces 2007 third quarter results 5SemBioSys announces 2007 third quarter results 6SemBioSys announces 2007 third quarter results 7SemBioSys announces 2007 third quarter results 8SemBioSys announces 2007 third quarter results 9SemBioSys announces 2007 third quarter results 10SemBioSys announces 2007 third quarter results 11SemBioSys announces 2007 third quarter results 12Human Genome Sciences Completes Enrollment Ahead of Schedule in Second Phase 3 Albuferon(R) Trial 2Human Genome Sciences Completes Enrollment Ahead of Schedule in Second Phase 3 Albuferon(R) Trial 3Human Genome Sciences Completes Enrollment Ahead of Schedule in Second Phase 3 Albuferon(R) Trial 4Human Genome Sciences Completes Enrollment Ahead of Schedule in Second Phase 3 Albuferon(R) Trial 5Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes 2Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes 3Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes 4
(Date:12/16/2009)... European Union (EU) member states are spending ... increasingly subjected to unauthorised immigration and illegal ... security and IT-based systems will boost the ... ) ,, New analysis from Frost & ... Market Assessment - European Union , finds ...
(Date:12/15/2009)... The 2009 Frost & Sullivan ... presented to Sagem Securite (Safran Group) for ... award recognises the company,s expertise in advanced ... offering novel, value-added products to end users. ... ,, "Sagem Securite has been involved in ...
(Date:12/15/2009)... babies are born, they are susceptible to diseases and ... a month, their immune systems aren,t adequately developed to ... can lead to serious problems if left untreated. To ... have pinpointed a group of depleted white blood cells, ... trying to improve the immune system of newborns to ...
Breaking Biology News(10 mins):Increased Spending on the EU's External Borders to Drive the Border Security Market, Says Frost & Sullivan 2Increased Spending on the EU's External Borders to Drive the Border Security Market, Says Frost & Sullivan 3Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 2Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 3Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 4Researchers work on vaccine to improve immune system in newborns 2NFL Cardinals Wide Receiver Larry Fitzgerald Promotes Vision Therapy 53382 1NFL Cardinals Wide Receiver Larry Fitzgerald Promotes Vision Therapy 53382 2NFL Cardinals Wide Receiver Larry Fitzgerald Promotes Vision Therapy 53382 3NFL Cardinals Wide Receiver Larry Fitzgerald Promotes Vision Therapy 53382 4Duane Reade Holdings Inc Announces Pricing of Offering of 11 75 25 Senior Secured Notes Due 2015 53380 1Duane Reade Holdings Inc Announces Pricing of Offering of 11 75 25 Senior Secured Notes Due 2015 53380 2Duane Reade Holdings Inc Announces Pricing of Offering of 11 75 25 Senior Secured Notes Due 2015 53380 3Thoratec Corporation and HeartWare International Inc Announce Termination of Proposed Transaction 53378 1Thoratec Corporation and HeartWare International Inc Announce Termination of Proposed Transaction 53378 2Thoratec Corporation and HeartWare International Inc Announce Termination of Proposed Transaction 53378 3
... got its moment in the spotlight. Peter et ... cells might ameliorate the most severe form of ... mutated dystrophin protein fails to anchor correctly to ... muscle cells experience severe contraction-induced damage. Sarcospan is ...
... CAMBRIDGE, Mass. -- Scientists have long known that it,s possible ... same protein by skipping or including certain sequences from the ... phenomenon, known as alternative splicing, is both far more prevalent ... , Nearly all human genes, about 94 percent, generate more ...
... blood and plasma to clota process that was previously ... vertebrate evolution, according to new research at the University ... and Institut Pasteur in Paris. Their findings will be ... . , The discovery will improve scientists, understanding of ...
Other Biology News:Human genes sing different tunes in different tissues 2Nature study demonstrates that bacterial clotting depends on clustering 2
... Cell Lines ,High Quality, Functionally-Validated, Ion Channel ... known for having a critical role in ... a key function in pain, CNS and ... have been investigated in therapeutic areas, such ...
... Channel Cell Lines ,High Quality, Functionally-Validated, Ion ... well known for having a critical role ... have a key function in pain, CNS ... channels have been investigated in therapeutic areas, ...
Mouse monoclonal antibody raised against a partial recombinant ENTPD5. NCBI Entrez Gene ID = ENTPD5...
Mouse monoclonal antibody raised against a partial recombinant TTC3. NCBI Entrez Gene ID = TTC3...
Biology Products: